Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Genaera, a biopharmaceutical company, has reported a net loss of $3.4 million, or $(0.19) per basic and diluted share, for the three-month period ended September 30, 2008 as compared to a net loss of $3.7 million, or $(0.21) per basic and diluted share, for the three-month period ended September 30, 2007.
Subscribe to our email newsletter
The net loss for the nine-month period ended September 30, 2008 was $12.4 million, or $(0.71) per basic and diluted share, as compared to a net loss of $9.9 million, or $(0.57) per basic and diluted share, for the nine-month period ended September 30, 2007.
The company has reported revenues of $92,000 for the three-month period ended September 30, 2008 as compared to $51,000 for the corresponding period of 2007.
For the nine-month period ended September 30, 2008, the company posted revenues of $1.44 million as compared to $2.6 million for the same period of 2007.